FI20070795A0 - Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin - Google Patents

Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Info

Publication number
FI20070795A0
FI20070795A0 FI20070795A FI20070795A FI20070795A0 FI 20070795 A0 FI20070795 A0 FI 20070795A0 FI 20070795 A FI20070795 A FI 20070795A FI 20070795 A FI20070795 A FI 20070795A FI 20070795 A0 FI20070795 A0 FI 20070795A0
Authority
FI
Finland
Prior art keywords
therapies
assessing
efficacy
disease development
controlling disease
Prior art date
Application number
FI20070795A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Sirpa Jalkanen
Marko Salmi
Markku Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Priority to FI20070795A priority Critical patent/FI20070795A0/fi
Publication of FI20070795A0 publication Critical patent/FI20070795A0/fi
Priority to US12/679,785 priority patent/US20100209942A1/en
Priority to PL08842581T priority patent/PL2201376T3/pl
Priority to KR1020167005473A priority patent/KR20160029869A/ko
Priority to KR1020107006430A priority patent/KR20100059902A/ko
Priority to ES12002502.8T priority patent/ES2532361T3/es
Priority to EP08842581A priority patent/EP2201376B1/en
Priority to SI200830723T priority patent/SI2201376T1/sl
Priority to DK12002502T priority patent/DK2503338T3/en
Priority to JP2010530497A priority patent/JP4982610B2/ja
Priority to PT12002502T priority patent/PT2503338E/pt
Priority to PCT/FI2008/050576 priority patent/WO2009053523A1/en
Priority to PT08842581T priority patent/PT2201376E/pt
Priority to SI200831377T priority patent/SI2503338T1/sl
Priority to DK08842581.4T priority patent/DK2201376T3/da
Priority to EP12002502.8A priority patent/EP2503338B1/en
Priority to ES08842581T priority patent/ES2389751T3/es
Priority to PL12002502T priority patent/PL2503338T3/pl
Priority to HRP20120743AT priority patent/HRP20120743T1/hr
Priority to CA2702635A priority patent/CA2702635A1/en
Priority to JP2012098081A priority patent/JP5619810B2/ja
Priority to CY20121100924T priority patent/CY1113403T1/el
Priority to US13/775,558 priority patent/US8975081B2/en
Priority to HRP20150181TT priority patent/HRP20150181T1/hr
Priority to CY20151100234T priority patent/CY1116089T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
FI20070795A 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin FI20070795A0 (fi)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
CA2702635A CA2702635A1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
PT12002502T PT2503338E (pt) 2007-10-24 2008-10-15 Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias
PT08842581T PT2201376E (pt) 2007-10-24 2008-10-15 Um novo biomarcador para monitorizar o desenvolvimento de doenças e avaliar a eficácia de tratamentos
KR1020167005473A KR20160029869A (ko) 2007-10-24 2008-10-15 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커
KR1020107006430A KR20100059902A (ko) 2007-10-24 2008-10-15 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커
ES12002502.8T ES2532361T3 (es) 2007-10-24 2008-10-15 CD73 como biomarcador para monitorizar el desarrollo de enfermedades y evaluar la eficacia de terapias
EP08842581A EP2201376B1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
SI200830723T SI2201376T1 (sl) 2007-10-24 2008-10-15 Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij
DK12002502T DK2503338T3 (en) 2007-10-24 2008-10-15 CD73 as a biomarker to monitor the development of disease and evaluate the effectiveness of treatments
JP2010530497A JP4982610B2 (ja) 2007-10-24 2008-10-15 疾患の進展をモニターするための、および治療法の有効性を評価するための新規なバイオマーカー
US12/679,785 US20100209942A1 (en) 2007-10-24 2008-10-15 New biomarker for monitoring development of diseases and assessing the efficacy of therapies
PCT/FI2008/050576 WO2009053523A1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
PL08842581T PL2201376T3 (pl) 2007-10-24 2008-10-15 Nowy biomarker do monitorowania rozwoju chorób i do oceny skuteczności leczenia
SI200831377T SI2503338T1 (sl) 2007-10-24 2008-10-15 CD73 kot biomarker za spremljanje razvoja bolezni in ocenjevanje učinkovitosti terapij
DK08842581.4T DK2201376T3 (da) 2007-10-24 2008-10-15 En ny biomarkør til overvågning af udviklingen af sygdomme og vurdering af effektiviteten af terapier
EP12002502.8A EP2503338B1 (en) 2007-10-24 2008-10-15 CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
ES08842581T ES2389751T3 (es) 2007-10-24 2008-10-15 Un nuevo biomarcador para monitorizar el desarrollo de enfermedades y evaluar la eficacia de terapias
PL12002502T PL2503338T3 (pl) 2007-10-24 2008-10-15 CD73 jako biomarker do monitorowania rozwoju choroby i oceny skuteczności terapii
HRP20120743AT HRP20120743T1 (hr) 2007-10-24 2008-10-15 Novi biomarker za nadzor razvoja bolesti i procjenu uäśinkovitosti lijeäśenja
JP2012098081A JP5619810B2 (ja) 2007-10-24 2012-04-23 疾患の進展をモニターするための、および治療法の有効性を評価するための新規なバイオマーカー
CY20121100924T CY1113403T1 (el) 2007-10-24 2012-10-04 Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων
US13/775,558 US8975081B2 (en) 2007-10-24 2013-02-25 Biomarker for monitoring development of diseases and assessing the efficacy of therapies
HRP20150181TT HRP20150181T1 (hr) 2007-10-24 2015-02-16 Cd73 kao biomarker za praä†enje razvoja bolesti i procjenu uäśinkovitosti lijeäśenja
CY20151100234T CY1116089T1 (el) 2007-10-24 2015-03-06 Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Publications (1)

Publication Number Publication Date
FI20070795A0 true FI20070795A0 (fi) 2007-10-24

Family

ID=38656804

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Country Status (14)

Country Link
US (1) US20100209942A1 (https=)
EP (2) EP2201376B1 (https=)
JP (2) JP4982610B2 (https=)
KR (2) KR20100059902A (https=)
CA (1) CA2702635A1 (https=)
CY (2) CY1113403T1 (https=)
DK (2) DK2201376T3 (https=)
ES (2) ES2389751T3 (https=)
FI (1) FI20070795A0 (https=)
HR (2) HRP20120743T1 (https=)
PL (2) PL2201376T3 (https=)
PT (2) PT2503338E (https=)
SI (2) SI2503338T1 (https=)
WO (1) WO2009053523A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
AU2011281012A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting cardiovascular diseases or conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
PL2956772T3 (pl) * 2013-02-14 2018-12-31 Faron Pharmaceuticals Oy Sposób określenia biomarkerów związanych z zespołem ostrej niewydolności oddechowej (ARDS), sposób monitorowania rozwoju i leczenia ARDS u pacjenta
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
AU2015349878A1 (en) 2014-11-21 2017-05-25 Bristol-Myers Squibb Company Antibodies against CD73 and uses thereof
JP6668345B2 (ja) 2014-11-21 2020-03-18 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 修飾された重鎖定常領域を含む抗体
GB201706747D0 (en) * 2017-04-27 2017-06-14 Queen Mary Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515965A (ja) * 1995-08-18 2002-05-28 ダブリュー． ランドリ，ドナルド 抗体触媒反応の調節による有機化合物の検出
EP0862652A1 (en) 1995-10-13 1998-09-09 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy
HUP0002003A3 (en) 2000-05-24 2003-01-28 Pronuk Biotechnologia Kft Process and reagent-kit for determining of 5'-nucleotidase activity
CA2439961A1 (en) * 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
WO2004079013A1 (en) * 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
FI20030467A0 (fi) * 2003-03-28 2003-03-28 Sirpa Jalkanen Menetelmä tulehdustilojen hoitamiseen
US7534423B2 (en) 2003-03-28 2009-05-19 Faron Pharmaceuticals Oy Method for inducing an elevated level of adenosine in an individual
CA2528152A1 (en) * 2003-06-03 2005-01-06 The Regents Of The University Of California Compositions and methods for treatment of disease with acetylated disaccharides
JP2009505658A (ja) * 2005-08-24 2009-02-12 ブリストル−マイヤーズ スクイブ カンパニー 上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
FI20051003A0 (fi) 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
EP2021350B1 (en) * 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
EP2041574B1 (en) * 2006-07-14 2016-11-16 The Regents of The University of California Cancer biomarkers and methods of use threof

Also Published As

Publication number Publication date
PT2503338E (pt) 2015-03-05
WO2009053523A1 (en) 2009-04-30
CA2702635A1 (en) 2009-04-30
ES2532361T3 (es) 2015-03-26
EP2201376B1 (en) 2012-08-08
EP2503338B1 (en) 2014-12-24
JP5619810B2 (ja) 2014-11-05
PL2201376T3 (pl) 2013-01-31
SI2503338T1 (sl) 2015-06-30
US20100209942A1 (en) 2010-08-19
HRP20120743T1 (hr) 2012-10-31
EP2201376A1 (en) 2010-06-30
JP2012159514A (ja) 2012-08-23
EP2201376A4 (en) 2011-03-23
DK2201376T3 (da) 2012-10-15
JP4982610B2 (ja) 2012-07-25
ES2389751T3 (es) 2012-10-31
CY1116089T1 (el) 2017-02-08
PL2503338T3 (pl) 2015-06-30
EP2503338A2 (en) 2012-09-26
JP2011501176A (ja) 2011-01-06
CY1113403T1 (el) 2016-06-22
KR20160029869A (ko) 2016-03-15
SI2201376T1 (sl) 2012-09-28
KR20100059902A (ko) 2010-06-04
DK2503338T3 (en) 2015-03-09
HRP20150181T1 (hr) 2015-06-19
EP2503338A3 (en) 2013-03-13
PT2201376E (pt) 2012-08-20

Similar Documents

Publication Publication Date Title
FI20070795A0 (fi) Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
DK1867905T3 (da) Radiusregulering
EP2063322A4 (en) Toner
DE602007000609D1 (de) Toner
BRPI0813942A2 (pt) Polipeptídio ace2
DK2129781T3 (da) Hafnia-phytase
EP2157482A4 (en) MAGNETIC TONER
DK2602263T3 (da) Polypeptider omfattende en isbindende aktivitet
EP2011869A4 (en) NEW ANTI-CD98 ANTIBODY
FI20070344A0 (fi) Testitapausten suorittamisen optimointimenetelmä ja -järjestelmä
DE502007001007D1 (de) Kassette für Kantenmaterial
DE602007008778D1 (de) Flüssigentwickler
ATE450236T1 (de) Wundverband
SE0601174L (sv) Anordning för bestämning av bränsleförbrukningsbeteende
EP2012389A4 (en) Coil part
EP2017315A4 (en) DUCT TAPE
FI20065065L (fi) Jauhin
FI20061090A0 (sv) Förfarande för kontroll av skick
FR2901373B3 (fr) Cartouche toner
ITMI20060943A1 (it) Nessuno
DE502007001092D1 (de) Schalldämpferboden
FI20061064A0 (fi) Uudet ohutkalvorakenteet
FR2906556B1 (fr) Abri
DE602005007964D1 (de) Verkleidung für einen Medienspieler
DE502006007848D1 (de) Verladevorrichtung

Legal Events

Date Code Title Description
FD Application lapsed